Cargando…
Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy
Fasting reduces glucose levels and protects mice against chemotoxicity, yet drugs that promote hyperglycemia are widely used in cancer treatment. Here, we show that dexamethasone (Dexa) and rapamycin (Rapa), commonly administered to cancer patients, elevate glucose and sensitize cardiomyocytes and m...
Autores principales: | Di Biase, Stefano, Shim, Hong Seok, Kim, Kyung Hwa, Vinciguerra, Manlio, Rappa, Francesca, Wei, Min, Brandhorst, Sebastian, Cappello, Francesco, Mirzaei, Hamed, Lee, Changhan, Longo, Valter D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373519/ https://www.ncbi.nlm.nih.gov/pubmed/28358805 http://dx.doi.org/10.1371/journal.pbio.2001951 |
Ejemplares similares
-
Correction: Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy
por: Di Biase, Stefano, et al.
Publicado: (2017) -
Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity
por: Brandhorst, Sebastian, et al.
Publicado: (2019) -
Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012) -
Safety and feasibility of fasting in combination with platinum-based chemotherapy
por: Dorff, Tanya B., et al.
Publicado: (2016) -
Dietary restriction with and without caloric restriction for healthy aging
por: Lee, Changhan, et al.
Publicado: (2016)